FIELD: medicine.
SUBSTANCE: application of ambroxol or its pharmaceutically acceptable salts is proposed to produce medical composition intended for treatment or prophylactics of infections caused by human rhinovirus. It is proven that ambroxol suppresses replication of human rhinovirus in vitro.
EFFECT: ambroxol in medical composition is suitable for treatment or prophylactics of all symptoms of rhinovirus infection and has direct antivirus effect.
9 cl, 6 tbl, 6 ex
Authors
Dates
2011-01-20—Published
2006-08-03—Filed